ProdigEye is a medical-grade AI diagnostic platform that enables non-specialist clinicians to accurately identify anterior segment eye diseases using only a standard smartphone camera. Designed for primary care, pediatrics, and emergency settings, ProdigEye delivers specialist-level diagnostic insight at the point of care, helping reduce misdiagnosis, unnecessary referrals, and delays in treatment where access to ophthalmologists and ocular equipment is limited.
ProdigEye transforms a smartphone into a clinical eye diagnostic tool. Using AI-powered image analysis, the platform supports early and accurate identification of anterior segment eye conditions directly at the point of care. By reducing diagnostic uncertainty and unnecessary emergency room referrals, ProdigEye improves clinical confidence, lowers healthcare costs, and ensures patients receive timely, appropriate care, without requiring additional hardware or specialist training.
Co-Founder & CEO
Ron is responsible for the company's core technology, from model architecture to technical strategy. He is a proven AI leader and entrepreneur with over 20 years of experience. His career is highlighted by founding and selling his own AI company, Algotrace, to a major international high-tech firm. Ron holds a Master's degree in Statistics from the University of Haifa.
Co-Founder & Chief Medical Officer
Dr. Fisher is an American board-certified Ophthalmologist specializing in Cornea & External Disease with 27 years of clinical experience. He earned his medical degree from Albert Einstein College of Medicine in New York, completed his Ophthalmology residency at Long Island Jewish Medical Center, and pursued an advanced fellowship in Cornea and External Disease at Mount Sinai–NYU. He previously served as Assistant Director of the Cornea Service and Assistant Clinical Professor at the University of Medicine & Dentistry of New Jersey. He is currently the Director of the Modiin Eye Center in Modiin, Israel.
